ipsapirone has been researched along with Drug Withdrawal Symptoms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cutler, NR; Keppel Hesselink, JM; Krol, A; Rickels, K; Roeschen, J; Schweizer, E; Sramek, JJ | 1 |
| Cutler, N; Keppel Hesselink, JM; Mandos, LA; Rickels, K; Roeschen, J; Schweizer, E | 1 |
| Bologa, M; Bremner, KE; Busto, UE; Naranjo, CA; Peachey, JE | 1 |
| Heaton, M; Marsden, CA; Upton, N; Wright, IK | 1 |
| Costall, B; Domeney, AM; Farre, AJ; Kelly, ME; Martinez, L; Naylor, RJ | 1 |
| Goudie, AJ; Leathley, MJ | 1 |
3 trial(s) available for ipsapirone and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Double-Blind Method; Female; Humans; Lorazepam; Male; Prospective Studies; Psychiatric Status Rating Scales; Pyrimidines; Substance Withdrawal Syndrome | 1993 |
Placebo-controlled comparison of the clinical effects of rapid discontinuation of ipsapirone and lorazepam after 8 weeks of treatment for generalized anxiety disorder.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Female; Humans; Lorazepam; Male; Placebo Effect; Psychiatric Status Rating Scales; Pyrimidines; Substance Withdrawal Syndrome; Treatment Outcome | 1995 |
Safety of ipsapirone treatment compared with lorazepam: discontinuation effects.
Topics: Adult; Anti-Anxiety Agents; Double-Blind Method; Humans; Lorazepam; Male; Prospective Studies; Pyrimidines; Substance Withdrawal Syndrome | 1998 |
3 other study(ies) available for ipsapirone and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze.
Topics: Adrenergic alpha-Antagonists; Animals; Anti-Anxiety Agents; Diazepam; Dioxanes; Idazoxan; Imidazoles; Male; Ondansetron; Pyrimidines; Rats; Ritanserin; Serotonin; Serotonin Antagonists; Substance Withdrawal Syndrome | 1992 |
Profile of action of a novel 5-hydroxytryptamine1A receptor ligand E-4424 to inhibit aversive behavior in the mouse, rat and marmoset.
Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Buspirone; Callithrix; Diazepam; Female; Guinea Pigs; Injections, Intraperitoneal; Male; Mice; Muscle Contraction; Muscle, Smooth; Piperazines; Pyrimidines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin Antagonists; Substance Withdrawal Syndrome | 1992 |
Evaluation of the dependence potential of the selective 5-H1A agonist ipsapirone in rats and of its effects on benzodiazepine withdrawal.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Body Weight; Feeding Behavior; Male; Pyrimidines; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome | 1991 |